Severe reaction to diphosphonate: implications for treatment of Paget's disease.
D002990:Clobetasol / Q000031:analogs & derivatives / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology*; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy; D013669:Technetium Tc 99m Medronate / Q000009:adverse effects*; D014657:Vasculitis / Q000139:chemically induced* / Q000188:drug therapy
D002990:Clobetasol; D013669:Technetium Tc 99m Medronate